Manel Sabate

Summary

Country: Spain

Publications

  1. doi request reprint The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial
    Manel Sabate
    University Hospital Clinic, IDIBAPS, Cardiology Department, Barcelona, Spain Electronic address
    JACC Cardiovasc Interv 7:64-71. 2014
  2. doi request reprint Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry
    Manel Sabate
    Hospital Clinic, Barcelona, Spain Electronic address
    Int J Cardiol 168:2522-7. 2013
  3. doi request reprint Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
    Manel Sabate
    University Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Lancet 380:1482-90. 2012
  4. doi request reprint Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction
    Manel Sabate
    University Hospital Clinic, Barcelona, Spain
    EuroIntervention 7:977-84. 2011
  5. ncbi request reprint Emergent versus elective percutaneous stent implantation in the unprotected left main: long-term outcomes from a single-center registry
    Victoria Martin-Yuste
    Department of Cardiology, Clinic Thorax Institute, Hospital Clinic de Barcelona, Villaroel 170, Planta 6 Esc 3, 08036, Barcelona, Spain
    J Invasive Cardiol 23:392-7. 2011
  6. doi request reprint Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry
    Victoria Martin-Yuste
    Interventional Cardiology Unit, University Hospital of Saint Paul, Barcelona, Spain
    EuroIntervention 6:831-7. 2011
  7. doi request reprint [Usefulness of the Tornus® catheter in nondilatable coronary chronic total occlusion]
    Victoria Martin-Yuste
    Sección de Hemodinámica, Servicio de Cardiologia, Hospital Clinic, Universidad de Barcelona, Barcelona, Espana
    Rev Esp Cardiol 64:935-8. 2011
  8. doi request reprint Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial
    Salvatore Brugaletta
    University Hospital Clinic, IDIBAPS, Barcelona, Spain
    Int J Cardiol 168:2632-6. 2013
  9. doi request reprint Percutaneous transcatheter aortic valve implantation: present and future perspective
    Diego Fernandez
    Thorax Institute, Hospital Clinic, University of Barcelona, IDIBAPS, C Villarroel 170, 08036 Barcelona, Spain
    Expert Rev Med Devices 10:185-99. 2013
  10. ncbi request reprint Transcatheter aortic valve implantation in patients with left main percutaneous coronary intervention
    Joaquim Cevallos
    Department of Cardiology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
    J Heart Valve Dis 22:874-7. 2013

Collaborators

Detail Information

Publications25

  1. doi request reprint The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial
    Manel Sabate
    University Hospital Clinic, IDIBAPS, Cardiology Department, Barcelona, Spain Electronic address
    JACC Cardiovasc Interv 7:64-71. 2014
    ....
  2. doi request reprint Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry
    Manel Sabate
    Hospital Clinic, Barcelona, Spain Electronic address
    Int J Cardiol 168:2522-7. 2013
    ..Outcome of sirolimus-eluting stent (SES) in patients treated with an antivitamin K (VKA) agent before the PCI procedure is unknown...
  3. doi request reprint Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial
    Manel Sabate
    University Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain
    Lancet 380:1482-90. 2012
    ..We report the 1-year result of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) trial, comparing EES with bare-metal stents (BMS) in patients with STEMI...
  4. doi request reprint Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction
    Manel Sabate
    University Hospital Clinic, Barcelona, Spain
    EuroIntervention 7:977-84. 2011
    ..There are however few data regarding the effectiveness of EES in the context of STEMI...
  5. ncbi request reprint Emergent versus elective percutaneous stent implantation in the unprotected left main: long-term outcomes from a single-center registry
    Victoria Martin-Yuste
    Department of Cardiology, Clinic Thorax Institute, Hospital Clinic de Barcelona, Villaroel 170, Planta 6 Esc 3, 08036, Barcelona, Spain
    J Invasive Cardiol 23:392-7. 2011
    ..The aim of this study was to evaluate ULM-PCI as a feasible and safe procedure in the emergent setting, and to analyze outcomes in both scenarios...
  6. doi request reprint Endothelial progenitor cell capturing stent and short dual antiplatelet therapy in patients on chronic anti-vitamin k regimen undergoing percutaneous coronary interventions: long-term outcomes of a single centre registry
    Victoria Martin-Yuste
    Interventional Cardiology Unit, University Hospital of Saint Paul, Barcelona, Spain
    EuroIntervention 6:831-7. 2011
    ..To evaluate outcomes of the endothelial progenitor cell (EPC) capture stent in patients on chronic anti-vitamin K (AVK) regimen, requiring percutaneous coronary intervention (PCI)...
  7. doi request reprint [Usefulness of the Tornus® catheter in nondilatable coronary chronic total occlusion]
    Victoria Martin-Yuste
    Sección de Hemodinámica, Servicio de Cardiologia, Hospital Clinic, Universidad de Barcelona, Barcelona, Espana
    Rev Esp Cardiol 64:935-8. 2011
    ..The use of the Tornus® catheter is safe and feasible in those patients with CTO lesions in whom balloon angioplasty has been unsuccessful...
  8. doi request reprint Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial
    Salvatore Brugaletta
    University Hospital Clinic, IDIBAPS, Barcelona, Spain
    Int J Cardiol 168:2632-6. 2013
    ..We sought to investigate the predictors and clinical implications of 1-year stent thrombosis (ST) in patients with STEMI, included in the EXAMINATION trial...
  9. doi request reprint Percutaneous transcatheter aortic valve implantation: present and future perspective
    Diego Fernandez
    Thorax Institute, Hospital Clinic, University of Barcelona, IDIBAPS, C Villarroel 170, 08036 Barcelona, Spain
    Expert Rev Med Devices 10:185-99. 2013
    ..Thus, the aim of the present paper is to review the salient features of the two most used systems today (third-generation CoreValve and Edwards SAPIEN XT(®)) as well as to provide data on other emerging valves and future perspectives...
  10. ncbi request reprint Transcatheter aortic valve implantation in patients with left main percutaneous coronary intervention
    Joaquim Cevallos
    Department of Cardiology, Hospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain
    J Heart Valve Dis 22:874-7. 2013
    ..Future studies will be necessary to provide more evidence for this indication...
  11. doi request reprint Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial
    Antonia Sambola
    Cardiology Department, Hospital Universitari Vall d Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain Electronic address
    Am Heart J 166:669-75. 2013
    ..In patients with AF requiring PCI-S, the association of DAPT and OAC carries an increased risk of bleeding, whereas OAC therapy or DAPT alone may not protect against the risk of developing new ischemic or thromboembolic events...
  12. pmc Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention
    Salvatore Brugaletta
    Salvatore Brugaletta, Victoria Martin Yuste, Luis Alvarez Contreras, Manel Sabaté, Thorax Institute, Department of Cardiology, Hospital Clinic, 08036 Barcelona, Spain
    World J Cardiol 3:367-73. 2011
    ..To investigate the impact of dual antiplatelet therapy (DAT) in patients on anti-vitamin K (AVK) regimen requiring percutaneous coronary intervention (PCI)...
  13. doi request reprint Factors determining success in percutaneous revascularization of chronic total coronary occlusion: multidetector computed tomography analysis
    Victoria Martin-Yuste
    Servicio de Cardiologia, Instituto del Tórax, Hospital Clinic, Barcelona, Spain
    Rev Esp Cardiol (Engl Ed) 65:334-40. 2012
    ..In this study, we investigate the multidetector computed tomography features associated with failure of percutaneous treatment for chronic total coronary occlusion...
  14. doi request reprint Isolated right ventricular infarction presenting with anterior ST-segment elevation: a case for careful assessment of right ventricular branch occlusion
    Sergio Nabais
    Interventional Cardiology Section, Cardiology Department, Thorax Institute, Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain
    Rev Port Cardiol 31:301-4. 2012
    ....
  15. pmc Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularization
    Clarissa Cola
    Department of Cardiology, Interventional Cardiology Unit, Sant Pau University Hospital, Barcelona, Spain
    Vasc Health Risk Manag 5:101-19. 2009
    ..Possible contributing factors that led to synergistic thrombotic effects are discussed...
  16. doi request reprint Lung Function Abnormalities are Highly Frequent in Patients with Heart Failure and Preserved Ejection Fraction
    Rut Andrea
    Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona, Spain Electronic address
    Heart Lung Circ 23:273-9. 2014
    ..In this study we explore the frequency, type and severity of lung function abnormalities in HFPEF...
  17. doi request reprint Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFO
    Manel Sabate
    University Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    JACC Cardiovasc Interv 7:55-63. 2014
    ....
  18. doi request reprint Improvement of myocardial function and perfusion after successful percutaneous revascularization in patients with chronic total coronary occlusion
    Sandra Pujadas
    Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Electronic address
    Int J Cardiol 169:147-52. 2013
    ..This study aimed to assess ventricular function and myocardial ischemia before and after PCI for CTO using cardiac magnetic resonance (CMR). NYHA functional class was also assessed before and after PCI...
  19. doi request reprint Everolimus-eluting stent versus bare metal stent in proximal left anterior descending ST-elevation myocardial infarction: insights from the EXAMINATION trial
    Josep Gomez-Lara
    Heart Institute, University Hospital of Bellvitge, Barcelona, Spain
    Am Heart J 166:119-26. 2013
    ..The aim is to compare outcomes of patients with STEMI and proximal-LAD lesions treated with bare-metal stents (BMS) versus everolimus-eluting stents (EES)...
  20. doi request reprint One-year head to head comparison of the neointimal response between sirolimus eluting stent with reservoir technology and everolimus eluting stent: an optical coherence tomography study
    Yoshitaka Shiratori
    Deparment of Cardiology, Thorax Institute, Hospital Clinic, University of Barcelona, Spain
    Catheter Cardiovasc Interv 82:E428-36. 2013
    ..to compare the vascular healing process between the sirolimus-eluting NEVO and the everolimus-eluting Xience stent by optical coherence tomography (OCT) at 1-year follow-up...
  21. doi request reprint Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year
    Ignacio Ferreira-Gonzalez
    Epidemiology Unit of the Cardiology Department, Vall d Hebron Hospital, and Red de Enfermedades Cardiovasculares RECAVA, Barcelona, Spain
    J Am Coll Cardiol 60:1333-9. 2012
    ..The goal of this study was to assess the risk associated with double antiplatelet therapy (DAT) discontinuation, and specifically, temporary discontinuation, during the first year after drug-eluting stent (DES) implantation...
  22. ncbi request reprint Left main coronary artery stenosis following surgical valve replacement: changing valvular into ischemic heart disease
    Clarissa Cola
    Interventional Cardiology Unit, Department of Cardiology, Sant Pau University Hospital, Barcelona, Spain
    J Invasive Cardiol 21:E9-11. 2009
    ..Here we discuss two cases of late presentation of iatrogenic coronary ostial stenosis following valve replacement surgery. Both cases were successfully treated with percutaneous intervention and stent implantation...
  23. ncbi request reprint Zotarolimus for the treatment of coronary artery disease: pathophysiology, DES design, clinical evaluation and future perspective
    Salvatore Brugaletta
    University Hospital of San Pau, Interventional Cardiology Department, Barcelona, Spain
    Expert Opin Pharmacother 10:1047-58. 2009
    ..Zotarolimus is an anti-proliferative drug used exclusively in the design of coronary drug eluting stent...
  24. doi request reprint [Integration between cardiology and primary care: impact on clinical practice]
    Carlos Falces
    Servicio de Cardiologia, Instituto Clínico del Tórax, Hospital Clinic, IDIBAPS, Universidad de Barcelona, Barcelona, Spain
    Rev Esp Cardiol 64:564-71. 2011
    ..The integrated care consists of a hospital cardiologist in each primary care clinic, shared clinical history, joint practice guidelines, consultation sessions, and other coordinating tools...
  25. ncbi request reprint Secondary revascularisation following intracoronary brachytherapy
    Manel Sabate
    Interventional Cardiology Unit, Cardiology Department, Sant Pau University Hospital, Barcelona, Spain
    EuroIntervention 5:D121-6. 2009
    ..This review describes the potentials and limitations of this therapy, as well as the current status in the drug-eluting stent era...